Navigation Links
Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
Date:1/31/2008

PALATINE, Ill., Jan. 31 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. (OTC Bulletin Board: ACPH) is pleased to announce that The NASDAQ Stock Market(R) has approved the Company's application to list its common stock on the NASDAQ Capital Market(R) ("NASDAQ"). The Company's common stock will commence trading on NASDAQ on February 4, 2008 under the trading symbol "ACUR".

"We are pleased to join the growing list of specialty pharmaceutical companies trading on NASDAQ," stated Andy Reddick, the Company's CEO. "We believe that our new NASDAQ listing will provide enhanced liquidity and visibility and we are looking forward to attracting research analyst coverage as a result of our listing."

About Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(R) (abuse deterrent) Technology and related product candidates.

Forward Looking Statements

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our Company's expectations and projections. The most significant of such risks and uncertainties include, but are not limited to, our ability, and the ability of King Pharmaceuticals Research and Development, Inc. and other pharmaceutical companies, if any, with whom we may license our Aversion(R) Technology, to obtain necessary regulatory approvals and commercialize products utilizing the Aversion(R) Technology, the ability to avoid infringement of patents, trademarks and other proprietary rights or trade secrets of third parties, and the ability to fulfill the FDA's requirements for approving our product candidates for commercial manufacturing and distribut
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
2. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
3. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
4. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
5. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
6. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
7. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
8. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
11. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... New York (PRWEB) November 22, 2014 ... on behalf of patients who allegedly developed Type 2 ... in the federal multidistrict litigation now underway in U.S. ... reports. According to court documents, the litigation will convene ... a.m. The Court has directed Lead Counsel for Plaintiffs ...
(Date:11/22/2014)... UWDress.com is gratified to introduce its new collection of ... company has also offered an attracting discount on these ... of wedding dresses, UWDress.com is good at manufacturing all ... gowns are provided over 20 colors, which have diverse ... famous for high quality. Therefore, its sales increased quickly ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... “Greenfield Naturals” was featured on NewsWatch as part ... the latest and coolest technology products available to consumers. ... conducted the product review and shared with viewers how ... , From pollution to hazardous substances in water, harmful ... to remove these chemicals, especially in water. , A ...
(Date:11/22/2014)... 2014 (HealthDay News) -- A clinical trial of hydroxyurea ... halted a year early because the results show it ... disease and reduce the risk of stroke. The ... medical centers in the United States and Canada, was ... and Blood Institute (NHLBI). Researchers compared monthly blood ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... loss, expert says , MONDAY, March 22 (HealthDay News) ... people with mild cognitive impairment, the stage before Alzheimer,s ... that we need to pay attention to this time ... starting to have problems forgetting things," study author Robert ...
... Infertile men ... the average man according to a new study published in the journal, Cancer. , ... San Francisco, Calif. (Vocus) March 22, ... prostate cancer than fertile men according to a new study published in the journal, Cancer., ...
... 22 The Single Party finally bought enough votes to get the Senate-passed healthcare reform through the House, but its victory celebrations ... since "healthcare reform" was first promoted in 1943. , ... , ... ...
... Blue Cross and Blue Shield of Georgia ... bring a regional clinic to Georgia from today, ... Clayton County , Henry County and Spalding County ... based on their financial and vision needs to receive free vision ...
... Across the Country to Make Smart Choices , ... , , ... ... WASHINGTON , March 22 The ...
... were 2.6 times more likely to get more dangerous disease ... risk that a man will develop the aggressive, potentially fatal ... my knowledge, this is the first study to identify a ... Thomas J. Walsh, an assistant professor of urology at the ...
Cached Medicine News:Health News:Brain Function May Drop Quickly Before Alzheimer's 2Health News:Male Infertility Significantly Increases Risk of Prostate Cancer 2Health News:Physicians Urged to Declare Independence from Government, Other Third Parties 2Health News:Physicians Urged to Declare Independence from Government, Other Third Parties 3Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 2Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 3Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 4Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 5Health News:National Restaurant Association Says Nutrition Information Provision Is Win for Consumers and Restaurants 2Health News:National Restaurant Association Says Nutrition Information Provision Is Win for Consumers and Restaurants 3Health News:Infertility Raises Risk of More Aggressive Prostate Cancer 2
(Date:11/21/2014)... , Nov. 20, 2014 Oxis International, Inc. ... , the election of Anthony J. Cataldo as ... Effective November 19, 2014, Ken Eaton ... the Board of Directors of Oxis International, Inc. to pursue ... has been named Chief Executive Officer of Oxis International, Inc. ...
(Date:11/21/2014)... 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... offering of $80,000,000 aggregate principal amount of 5.25% Convertible ... private offering within the United States ... buyers pursuant to Rule 144A under the Securities Act ... also granted the initial purchasers an option to purchase ...
(Date:11/18/2014)... ANGELES , Nov. 18, 2014  Sanguine ... development, patient engagement and study recruitment – will ... called Sangre, to help Pfizer Inc. find and ... (CIP) and their family members to participate in ... potentially identify DNA mutations and hopefully aid in ...
Breaking Medicine Technology:OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2
... , KNOXVILLE, Tenn., Dec. 2 ... nation,s largest provider of hospital-based clinical outsourcing, announced it ... two groups in South Carolina and Illinois. , An ... S.C., will allow TeamHealth Teleradiology to provide services for ...
... , WALTHAM, Mass. and NEW YORK, Dec. ... and NYU Langone Medical Center announced findings from a study ... osteoarthritis have been published this week in the "Online First" ... at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf . Results from ...
Cached Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... use with metered dose inhalers., ,ACE ... from MDI canisters. Its versatile design allows ... circuit, in conjunction with an endotracheal airway ... inhalation. ACE may also be used in ...
Medicine Products: